Bryan  Love  to  Neoplasms
                            
                            
                                This is a "connection" page, showing publications  Bryan  Love  has written about  Neoplasms.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.071
         
        
        
     
 
    
        
        - 
            Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
            
            
                Score: 0.053
             
- 
            Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
            
            
                Score: 0.018